Repare Therapeutics Files 8-K on Officer/Director Changes
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Repare Therapeutics 8-K: Leadership changes and disclosures filed March 31st.
AI Summary
Repare Therapeutics Inc. filed an 8-K on March 31, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits.
Why It Matters
This filing provides updates on the company's leadership and governance, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing changes in directors and officers, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
FAQ
What specific events are detailed in the 8-K filing?
The 8-K filing details the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 31, 2025.
What is the principal executive office address of Repare Therapeutics Inc.?
The principal executive office address is 7171 Frederick-Banting, Building 2 Suite 270, St-Laurent, Quebec, Canada, H4S 1Z9.
What is the SIC code for Repare Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Repare Therapeutics Inc. is 2834, Pharmaceutical Preparations.
What other items are included in this 8-K filing besides director and officer information?
This 8-K filing also includes Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Repare Therapeutics Inc..